Bacteria can develop resistance to beta-lactam antibiotics through several mechanisms involving PBPs. One common method is the modification of PBPs to reduce their affinity for antibiotics, rendering the drugs less effective. This can occur through gene mutation or the acquisition of new PBP genes via horizontal gene transfer. Monitoring these resistance mechanisms is crucial for epidemiologists to develop strategies to combat antibiotic-resistant infections.
